Carotid Restenosis: Incidence, Pathophysiology and Therapeutic Options

Area of Science:

• Vascular Surgery
• Interventional Cardiology
• Cardiovascular Disease

Background:

• Restenosis is a primary complication following carotid endarterectomy and stenting for carotid stenosis.
• The 2-year restenosis rate ranges from 6-12% for both surgical and endovascular treatments.
• Complex inflammatory processes underlie both early and late restenosis.

Purpose of the Study:

• To review the causes and management of restenosis after carotid revascularization.
• To identify key systemic risk factors contributing to restenosis.
• To discuss current non-procedural and procedural treatment strategies.

Main Methods:

• Literature review of studies on carotid stenosis treatment and restenosis.
• Analysis of etiological factors including inflammation and systemic risks.
• Evaluation of non-procedural (lifestyle, medical therapy) and procedural (surgical, endovascular) interventions.

Main Results:

• Systemic risk factors for restenosis include female gender, hypertension, diabetes, dyslipidemia, and smoking.
• Non-procedural management involves lifestyle changes and optimal medical therapy.
• Procedural management, primarily for symptomatic patients, encompasses various open and endovascular techniques.

Conclusions:

• Restenosis following carotid interventions is a complex issue influenced by inflammation and patient-specific factors.
• Effective management necessitates a personalized approach, integrating patient characteristics, plaque features, and treatment modality.
• Addressing systemic risk factors and optimizing medical therapy are essential components of care.